¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"target plasma"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
fresh frozen plasma
½Å¼±³Ãµ¿Ç÷Àå
human plasma protein fraction
»ç¶÷Ç÷Àå´Ü¹éºÐÀ²
interstitial plasma cell pneumonia
»çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
normal human plasma
Á¤»ó»ç¶÷Ç÷Àå
plasma
1. Ç÷Àå 2. ¿øÇüÁú, ¼¼Æ÷Áú
plasma cell
ÇüÁú¼¼Æ÷
plasma cell dyscrasia
ÇüÁú¼¼Æ÷Áúȯ
plasma cell granuloma
ÇüÁú¼¼Æ÷À°¾ÆÁ¾
plasma cell mastitis
ÇüÁú¼¼Æ÷À¯¹æ¿°
plasma cell myeloma
ÇüÁú¼¼Æ÷°ñ¼öÁ¾
plasma coagulase
Ç÷ÀåÀÀ°íÈ¿¼Ò
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma component transfusion
Ç÷À强ºÐ¼öÇ÷
plasma cross matching
Ç÷Àå±³Â÷½ÃÇè
plasma exchange
Ç÷À屳ȯ(¼ú)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antihemophilic plasma
Ç×Ç÷¿ìº´Ç÷Àå
blood plasma
Ç÷Àå
plasma cell
ÇüÁú¼¼Æ÷
plasma coagulase
Ç÷ÀåÀÀ°íÈ¿¼Ò
thromboplastin plasma component
Æ®·Òº¸ÇÃ¶ó½ºÆ¾Ç÷À强ºÐ
plasma cell dyscrasia
ÇüÁú¼¼Æ÷Áúȯ
effective renal plasma flow
À¯È¿ÄáÆÏÇ÷Àå·ù·®
plasma exchange
Ç÷À屳ȯ, Ç÷À屳ȯ¼ú
plasma volume expander
ÀΰøÇ÷ÀåÁõ·®Á¦
plasma coagulation factor
Ç÷ÀåÀÀ°íÀÎÀÚ
plasma thromboplastin factor
Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
plasma cell granuloma
ÇüÁú¼¼Æ÷À°¾ÆÁ¾
plasma hemoglobin
Ç÷ÀåÇ÷¾×¼Ò
plasma iron
Ç÷Àåö
plasma membrane
ÇüÁú¸·
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
plasma cell
ÇüÁú(û¡òõ)¼¼Æ÷
plasma cell
ÇüÁú¼¼Æ÷(û¡òõá¬øà).
plasma cell
ÇüÁú¼¼Æ÷
plasma cell
ÇüÁú¼¼Æ÷
plasma cell dyscrasia
ÇüÁú¼¼Æ÷ÀÌÈ¥ÈÁõ
plasma cell dyscrasia
ÇüÁú¼¼Æ÷Áúȯ(û¡òõá¬øàòðü´), ÇüÁú¼¼Æ÷Àå¾Ö(¡î¡äô), ÇüÁú¼¼Æ÷ÀÌÈ¥ÈÁõ(¡ì¶ûèûúñø)
plasma cell gingivostomatitis
ÇüÁú¼¼Æ÷ Ä¡Àº ±¸³»¿°
plasma cell leukemia
ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´
plasma cell leukemia
ÇüÁú¼¼Æ÷¼º ¹éÇ÷º´(û¡òõá¬øààõ ÛÜúìÜ»)
plasma cell leukemia
ÇüÁú¼¼Æ÷ ¹éÇ÷º´
plasma cell mastitis
ÇüÁú¼¼Æ÷¼ºÀ¯¹æ¿°(û¡òõá¬øààõêáÛ®æú)
plasma cell myeloma
ÇüÁú¼¼Æ÷ °ñ¼öÁ¾
plasma cell myeloma
ÇüÁú¼¼Æ÷°ñ¼öÁ¾(û¡òõá¬øàÍéâÐðþ)
plasma cell pneumonia
ÇüÁú¼¼Æ÷¼º Æó·Å.
plasma cell pneumonia
ÇüÁú¼¼Æ÷¼ºÆó·Å(û¡òõá¬øààõøËæú)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
single target multi-hit model
´ÜÀÏÇ¥Àû´Ù¹ßÀûÁß ¸ðµ¨
source-target distance, STD
¼±¿øÇ¥Àû°£°Å¸®
target
Ç¥Àû(øöîÜ)
target cell
Ç¥Àû¼¼Æ÷
target cell anemia
Ç¥ÀûÀûÇ÷±¸¼º ºóÇ÷(øöîÜ îåúìϹàõÞ¸úì).
target cell anemia
Ç¥ÀûÀûÇ÷?úÔºóÇ÷(øöîÜ îåúìϹàõÞ¸úì)
target configuration
°ú³á ¸ð¾ç (Ç¥Àû¸ð¾ç)
target configuration
°ú³á ¸ð¾ç (Ù¼åÆ)
target glands
Ç¥Àû¼±(øöîÜàÍ).
target lesion
Ç¥Àû º´º¯
target lesions
Ç¥Àûº´¼Ò, °ú³áº´¼Ò, ŸÄÉÆ®º´¼Ò
target organ
Ç¥ÀûÀå±â
target pattern
°ú³á ¾ç»ó
target sign
°ú³á ¡ÈÄ
target skin distance radiation
Ç¥ÀûÇǺΰŸ®¹æ»ç¼±
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½